SEC
Filings

Menu

Tabs Financials

SEC Filings

Filing date Form Description Filing Group View
PRER14A

Proxy soliciting materials. Revised preliminary material

Proxy Filings
View HTML
PRER14A

Proxy soliciting materials. Revised preliminary material

Proxy Filings
View HTML
PRER14A

Proxy soliciting materials. Revised preliminary material

Proxy Filings
View HTML
PRER14A

Proxy soliciting materials. Revised preliminary material

Proxy Filings
View HTML
PRER14A

Proxy soliciting materials. Revised preliminary material

Proxy Filings
View HTML
S-4/A

Pre-effective amendment to an S-4 filing

Registration Statements
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
S-4/A

Pre-effective amendment to an S-4 filing

Registration Statements
View HTML
S-4/A

Pre-effective amendment to an S-4 filing

Registration Statements
View HTML
S-3/A

Pre-effective amendment to an S-3 filing

Registration Statements
View HTML
S-3/A

Pre-effective amendment to an S-3 filing

Registration Statements
View HTML

Data provided by Kaleidoscope.

 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe